All Articles on Trial
‘Fighting back’ against COVID-19: Remembering a historic trialLisa Jackson, MD, MPH, Kaiser Permanente Washington senior investigator, recounts the genesis of a groundbreaking vaccine.
Youth under 18 eligible for COVID vaccine trial registryA registry started by KPWHRI last year has sped up studies needed to protect the world against the novel coronavirus.
Pandemic highlights need for pragmatic clinical trialsNow more than ever we can benefit from studies embedded in health-care systems to answer common clinical questions.
A healthy holiday topic—pragmatic trialsPragmatic trials address real-world issues. In his monthly newsletter, Dr. Eric B. Larson suggests asking your guests what's important to them as physicians, patients, and caregivers.
- Pneumococcal vaccine being tested in older adults
Lisa A. Jackson, MD, MPH, is leading a study of pneumococcal vaccine in older adults at six Vaccine and Treatment Evaluation Units (VTEUs) across the nation, including at Group Health. Dr. Jackson, a senior investigator at Group Health Research Institute, leads the Seattle-area VTEU. Dr. Jackson and her colleagues plan to see if a higher dose of a pneumococcal vaccine will create a stronger immune response in older adults who received an earlier-generation vaccine against pneumonia and other pneumococcal diseases.
- ← Previous
- 1
- 2 (current)
- Next →
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.